Clinical trial

Comparative Effectiveness of Two Initial Combination Therapies in Patients With Recent Onset Diabetes

NCT06246799

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-11-07

PhasePHASE3

Study timeline

Study start (actual)2024-11-07Date precision: day

Registry last updated2026-03-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes (Adult Onset)unresolved

Interventions

TirzepatideDRUG · verified · RxNorm: tirzepatide

PioglitazoneDRUG · verified · RxNorm: pioglitazone

SitagliptinDRUG · verified · RxNorm: sitagliptin

Metformin HCI XRDRUG

Sponsors & collaborators

The University of Texas Health Science Center at San Antoniolead sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Mapped research locations

San AntonioTexas, United States2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06246799 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.